Paediatric Consumer Health in Latvia

Paediatric consumer health is expected to register moderate current value growth in Latvia in 2025. Analgesics, and in particular ibuprofen, is expected to register the highest value growth, helped by easy-to-dose liquids and sachets. Brands also launch flavour upgrades, sugar-free claims and child-friendly droppers/syringes, supporting a premium mix without deterring uptake. Ibuprofen leads, as it is considered more effective and is often recommended by doctors and pharmacists.

The Paediatric Consumer Health in Latvia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Paediatric Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.